World's Best Scientists 2026 revealed!
International Journal of Drug Policy
H-index 45

International Journal of Drug Policy

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 591 119 289 32

Additional Metrics

Number of Best Scientists*: 452
Documents by Best Scientists*: 728
Top 100 Ranked Scientists*: 15
SCIMAGO H-index: 106
SCIMAGO SJR: 1.483
Impact Factor: 4.4

Overview

Top Research Topics at International Journal of Drug Policy?

International Journal of Drug Policy tackles a plethora of topics, such as Harm reduction, Psychiatry, Environmental health, Psychological intervention and Suicide prevention. It explores issues in Harm reduction which can be linked to other research areas like Public relations, Heroin, Drug and Harm. Psychiatry, which encompasses Substance abuse, Cannabis, Methadone and Addiction, is the main subject of the journal.

The journal connects the study in Environmental health with the closely related area of Syringe. It explores topics in Suicide prevention which can be helpful for research in disciplines like Injury prevention, Human factors and ergonomics and Occupational safety and health.

  • Harm reduction (25.10%)
  • Psychiatry (15.81%)
  • Environmental health (13.24%)

What are the most cited papers published in the journal?

  • The ‘risk environment’: a framework for understanding and reducing drug-related harm (800 citations)
  • Risk environments and drug harms: A social science for harm reduction approach (564 citations)
  • Initiation into prescription opioid misuse amongst young injection drug users (328 citations)

Research areas of the most cited articles at International Journal of Drug Policy:

The most cited publications aim to foster the development of research in Harm reduction, Psychiatry, Environmental health, Psychological intervention and Social psychology. The Harm reduction research tackled in the journal papers is interrelated with Suicide prevention which concerns subjects like Criminology. The published articles explore research in Psychiatry alongside concepts in Injury prevention and other areas of study in Cannabis.

What topics the last edition of the journal is best known for?

  • Law
  • Internal medicine
  • Social psychology

The previous edition focused in particular on these issues:

The foci of International Journal of Drug Policy are Harm reduction, Qualitative research, Psychiatry, Criminology and Opioid overdose. The research on Harm reduction featured in the journal combines topics in other fields like Warning system, Perceived harm and Environmental health. Environmental health research presented in International Journal of Drug Policy encompasses a variety of subjects, including Health utility and Disease.

The study of Health care and how it intertwines with concepts under Service (business), Nursing, Stigma (botany) and Face (sociological concept) were explored in the presented Qualitative research research. It dives deep in exploring the relationship between the study of Psychiatry and Naloxone. The research on Opioid overdose tackled can also make contributions to studies in the areas of Heroin, Law, Family income, Rate ratio and National Health Interview Survey.

The most cited articles from the last journal are:

  • Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions. (0 citations)
  • Gendered harms: The lack of evidence on treatment that is mandated by child protection services. (0 citations)
  • Alcohol and drinking within the lives of midlife women: A meta-study systematic review. (0 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in International Journal of Drug Policy (based on the number of publications) are:

  • Thomas Kerr (69 papers) absent at the last edition,
  • Evan Wood (56 papers) absent at the last edition,
  • Tim Rhodes (53 papers) absent at the last edition,
  • Jason Grebely (48 papers) published 1 paper at the last edition, 5 less than at the previous edition,
  • Carla Treloar (48 papers) published 1 paper at the last edition, 9 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in International Journal of Drug Policy (based on the number of publications) are:

  • University of British Columbia (196 papers) published 2 papers at the last edition, 21 less than at the previous edition,
  • University of New South Wales (171 papers) published 1 paper at the last edition, 22 less than at the previous edition,
  • National Drug and Alcohol Research Centre (142 papers) published 1 paper at the last edition, 10 less than at the previous edition,
  • University of London (106 papers) absent at the last edition,
  • Curtin University (99 papers) published 1 paper at the last edition, 8 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2022 edition, 3.70% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 23.08% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.69% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.23% of all publications and 50.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Impact of Nursing and Healthcare Policies on Drug Policies and Administration

The International Journal of Drug Policy also provides insights into how nursing and healthcare policies can impact drug policies and administration. Furthermore, understanding the environmental health aspect of psychiatry provides a unique perspective that underlines the links between the physical environment, conduct, and substance abuse.

Uniquely, nurses play a critical role in harm reduction and suicide prevention, being frontline healthcare providers. In this capacity, they collaborate with psychiatrists, physicians, social workers, and other healthcare providers to develop and implement comprehensive healthcare and treatment plans that live up to the best standards of patient care.

It's also essential for current and aspiring nurses to be familiar with the latest research on addiction and psychiatry. Therefore, accessing educational resources, such as pursuing nursing degrees at recognized institutions, would be quite beneficial. Among the leading schools for this, the top 10 best nursing schools in Rhode Island come highly recommended for their comprehensive nursing programs that include subjects on drug policy and its impacts on healthcare.

Being equipped with robust knowledge and understanding of drug policies is tremendously critical to nurses in their role of providing patient-centered care. Additionally, this knowledge impacts the development and institution of more effective healthcare policies, ultimately translating to improved patient outcomes.

Top Publications

  • Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”

    (2022)
    276 Citations
  • Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update.

    Benedikt Fischer;Tessa Robinson;Chris Bullen;Valerie Curran

    (2021)
    196 Citations
  • Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study.

    David Hammond;Samantha Goodman;Elle Wadsworth;Vicki Rynard

    (2020)
    121 Citations
  • Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.

    Farihah Ali;Cayley Russell;Frishta Nafeh;Jürgen Rehm

    (2021)
    115 Citations
  • Safer opioid distribution in response to the COVID-19 pandemic.

    Mark Tyndall

    (2020)
    85 Citations
  • COVID-19 and the health of people who use drugs: What is and what could be?

    Jason Grebely;Magdalena Cerdá;Tim Rhodes;Tim Rhodes

    (2020)
    80 Citations
  • "You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia.

    Emma L. Richard;Christine A. Schalkoff;Hannah M. Piscalko;Daniel L. Brook

    (2020)
    77 Citations
  • Access to cannabidiol without a prescription: A cross-country comparison and analysis.

    Iain S. McGregor;Elizabeth A. Cairns;Sarah Abelev;Rhys Cohen

    (2020)
    71 Citations
  • Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients

    (2021)
    66 Citations
  • Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs.

    Marianne Skov-Skov Bergh;Marianne Skov-Skov Bergh;Åse Marit Leere Øiestad;Michael H. Baumann;Inger Lise Bogen

    (2021)
    57 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare beyond traditional medical school, several online degree options offer accelerated paths to rewarding careers. Students looking to combine healthcare knowledge with leadership skills may explore an accelerated healthcare administration degree online. These programs emphasize management and policy, preparing graduates for roles in hospital administration and health services management.

Affordability is a key concern for many prospective students. Fortunately, numerous healthcare administration programs offer quality education at reduced costs, making them accessible for a wider audience without compromising on academic rigor.

Nursing remains a high-demand career with flexible educational options. Students aiming for advanced clinical practice can find some of the cheapest online fnp programs, designed to prepare them as Family Nurse Practitioners with a focus on primary care.

For those seeking a faster route to enter the nursing field, several cheapest accelerated nursing programs provide intensive, condensed coursework that enables quicker transitions from student to practicing nurse, balancing cost-efficiency with comprehensive training.

Best Scientists Contributing to This Journal

Recently Published Articles